Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junji Furuse

Showing results (51-60 of 348) with videos related to

Pageof 35
Sort By:
Cancer Science|October 24, 2007
Phase I study of sorafenib in Japanese patients with hepatocellular carcinomaJunji Furuse, Hiroshi Ishii, Kohei Nakachi, et al.
Journal of Gastroenterology and Hepatology|September 22, 2005
Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinomaJunji Furuse, Hiroshi Ishii, Michitaka Nagase, et al.
Liver Cancer|August 11, 2025
Patient and Physician Preferences for Add-On Systemic Therapy to Transarterial Chemoembolization for Hepatocellular Carcinoma in Japan: A Discrete Choice ExperimentJunji Furuse, Sachiyo Shirakawa, Ayako Fukui, et al.
Japanese Journal of Clinical Oncology|December 19, 2017
Chemotherapy for hepatocellular carcinoma: current status and future perspectivesMasafumi Ikeda, Chigusa Morizane, Makoto Ueno, et al.
Japanese Journal of Clinical Oncology|February 4, 2025
Update for: New developments in systemic therapy for advanced biliary tract cancerChigusa Morizane, Makoto Ueno, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology|February 3, 2025
Systemic therapy for hepatocellular carcinoma, from the early to the advanced stage: a Japanese perspectiveMasafumi Ikeda, Chigusa Morizane, Makoto Ueno, et al.
Japanese Journal of Clinical Oncology|May 26, 2021
Current status of medical treatment for gastroenteropancreatic neuroendocrine neoplasms and future perspectivesSusumu Hijioka, Chigusa Morizane, Masafumi Ikeda, et al.
Palliative Medicine Reports|July 5, 2021
Tramadol/Acetaminophen Combination Tablets in Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Single-Arm Phase II StudyDaisuke Naruge, Fumio Nagashima, Kirio Kawai, et al.
Japanese Journal of Clinical Oncology|April 24, 2014
Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinomaHiroyuki Takahashi, Hidenori Ojima, Hiroko Shimizu, et al.
Japanese Journal of Clinical Oncology|January 9, 2004
A phase I study of hepatic arterial infusion chemotherapy with zinostatin stimalamer alone for hepatocellular carcinomaHiroshi Ishii, Junji Furuse, Michitaka Nagase, et al.
Pageof 35

Showing results (51-60 of 348) with videos related to

Sort By:
Pageof 35
Cancer Science|October 24, 2007
Phase I study of sorafenib in Japanese patients with hepatocellular carcinomaJunji Furuse, Hiroshi Ishii, Kohei Nakachi, et al.
Journal of Gastroenterology and Hepatology|September 22, 2005
Adverse hepatic events caused by radiotherapy for advanced hepatocellular carcinomaJunji Furuse, Hiroshi Ishii, Michitaka Nagase, et al.
Liver Cancer|August 11, 2025
Patient and Physician Preferences for Add-On Systemic Therapy to Transarterial Chemoembolization for Hepatocellular Carcinoma in Japan: A Discrete Choice ExperimentJunji Furuse, Sachiyo Shirakawa, Ayako Fukui, et al.
Japanese Journal of Clinical Oncology|December 19, 2017
Chemotherapy for hepatocellular carcinoma: current status and future perspectivesMasafumi Ikeda, Chigusa Morizane, Makoto Ueno, et al.
Japanese Journal of Clinical Oncology|February 4, 2025
Update for: New developments in systemic therapy for advanced biliary tract cancerChigusa Morizane, Makoto Ueno, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology|February 3, 2025
Systemic therapy for hepatocellular carcinoma, from the early to the advanced stage: a Japanese perspectiveMasafumi Ikeda, Chigusa Morizane, Makoto Ueno, et al.
Japanese Journal of Clinical Oncology|May 26, 2021
Current status of medical treatment for gastroenteropancreatic neuroendocrine neoplasms and future perspectivesSusumu Hijioka, Chigusa Morizane, Masafumi Ikeda, et al.
Palliative Medicine Reports|July 5, 2021
Tramadol/Acetaminophen Combination Tablets in Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Single-Arm Phase II StudyDaisuke Naruge, Fumio Nagashima, Kirio Kawai, et al.
Japanese Journal of Clinical Oncology|April 24, 2014
Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinomaHiroyuki Takahashi, Hidenori Ojima, Hiroko Shimizu, et al.
Japanese Journal of Clinical Oncology|January 9, 2004
A phase I study of hepatic arterial infusion chemotherapy with zinostatin stimalamer alone for hepatocellular carcinomaHiroshi Ishii, Junji Furuse, Michitaka Nagase, et al.
Pageof 35